Recently, a group of Chinese scientists invented a technology to vaccinate genetically-edited cells in a human for the first time, outlining a major development in the field of genetics.
They used CRISPR-Cas9 technology, a new kind of gene-editing technique that hits a path to healing by using an enzyme to trim out an unwanted genetic code.
CRISPR-Cas9 is faster, cheaper and more precise gene-editing tool as compared to the others available until now for DNA. The scientist has the authority to cut out a genetically inherited cancer before it spreads in the body.
Apparently, they could also apply the same method to eliminate the disease by extracting the genes causing the sickness after it has already started to spread.
China is the first one to use it successfully on a human body. The other companies have yet to follow the trend.